Benzoxazolone-based FITC-conjugated fluorescent probe for locating in-vivo expression level of translocator protein (TSPO) during lung inflammation
Molecular Diversity · 2026
DOI: 10.1007/s11030-025-11192-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Diversity, 2026. Verfasst von Neelam Kumari und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cyclotron and Radiopharmaceutical Sciences (DCRS), Institute of Nuclear Medicine and Allied Sciences (INMAS), Defence Research & Developm…. Hauptthemen laut MEDLINE: Fluorescent Dyes, Pneumonia, Benzoxazoles, Receptors, GABA. Die Arbeit nennt 58 Literaturangaben. Gefördert von: University Grants Commission.
Abstract (Originalsprache)
Translocator protein 18 kDa (TSPO) has been a salient target for probing and monitoring inflammation in the central nervous system (CNS) and peripheral systems. Leveraging our previously developed, TSPO specific, modified acetamidobenzoxazolone derivative, the present work describes the synthesis and development of an optical probe for lung inflammation imaging: 2-(3,6-dihydroxy-9H-xanthen-9-yl)-5-(3-(3-(2-(methyl(phenyl)amino)-2-oxoethyl)-2-oxo-2,3-dihydrobenzo[d]oxazol-5-yl)thioureido)benzoic acid (FITC-MBP). The FITC-MBP is prepared through facile methodology by conjugating MBP to fluorophore dye FITC. Spectral properties remained equivalent to FITC dye with absorption and emission wavelength at 486 and 520 nm, respectively. Cellular uptake studies established overexpression of TSPO in lipopolysaccharide (LPS)-induced inflammation in H1299 lung cells. Reduced mean fluorescence intensity (MFI) during blocking experiments with PK11195 in flow cytometry suggests the specificity of the fluorescent probe towards TSPO. In-vivo optical imaging analysis on LPS-induced lung-inflamed balb/c mice revealed major sequestration of FITC-MBP in the lungs compared to control at 25 min post-injection that significantly decreased on pretreatment with PK11195 due to competitive binding to TSPO. On ground of these findings, we believe the novel fluorescent probe (FITC-MBP) might be utilized to visualize the overexpressed TSPO.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Cyclotron and Radiopharmaceutical Sciences (DCRS), Institute of Nuclear Medicine and Allied Sciences (INMAS), Defence Research & Development Organization, Brig S K Mazumdar Road, Delhi, 110054, India.
- Department of Chemistry, Sri Venkateswara College, University of Delhi, Delhi, India.
- Department of Chemistry, Graphic Era Hill University, Dehradun, Uttarakhand, India.
- Organic Synthesis Research Laboratory, Department of Chemistry, A.R.S.D. College, University of Delhi, New Delhi, India.
- Division of Cyclotron and Radiopharmaceutical Sciences (DCRS), Institute of Nuclear Medicine and Allied Sciences (INMAS), Defence Research & Development Organization, Brig S K Mazumdar Road, Delhi, 110054, India. anjani…
- Department of Chemistry, Babasaheb Bhimrao Ambedkar University, Lucknow, Uttar Pradesh, India. anjanik2003@gmail.com.
Förderung
- University Grants Commission
Zitieren
APA
Kumari, N., Adhikari, A., Bhagat, S., Mishra, A. K., & Tiwari, A. K. (2026). Benzoxazolone-based FITC-conjugated fluorescent probe for locating in-vivo expression level of translocator protein (TSPO) during lung inflammation. Molecular Diversity. https://doi.org/10.1007/s11030-025-11192-9
Vancouver
Kumari N, Adhikari A, Bhagat S, Mishra AK, Tiwari AK. Benzoxazolone-based FITC-conjugated fluorescent probe for locating in-vivo expression level of translocator protein (TSPO) during lung inflammation. Molecular Diversity. 2026. doi:10.1007/s11030-025-11192-9
BibTeX
@article{Kumari2026,
author = {Kumari, Neelam and Adhikari, Anupriya and Bhagat, Sunita and Mishra, Anil K and Tiwari, Anjani K},
title = {Benzoxazolone-based FITC-conjugated fluorescent probe for locating in-vivo expression level of translocator protein (TSPO) during lung inflammation},
journal = {Molecular Diversity},
year = {2026},
doi = {10.1007/s11030-025-11192-9}
}
EUVIMED